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Abstract 1 
Background 2 
Occupational exposure to some organic solvents may increase risk of breast cancer. 3 
Methods 4 
In a population-based case-control study, 1205 women diagnosed with primary breast cancer 5 
between 2009 and 2011 were drawn from the Western Australian Cancer Registry and matched 6 
to 1789 controls from the electoral roll.  Exposure to solvents was determined through telephone 7 
interviews using OccIDEAS. 8 
Results 9 
About a third of women were occupationally exposed to solvents.  Age adjusted breast cancer 10 
risks were elevated for women who had been exposed to aliphatic solvents odds ratio (OR) 1.21 11 
(95% CI 0.99 - 1.48) and aromatic solvents OR 1.21 (95% CI 0.97 - 1.52).  For most solvents the 12 
ORs were higher for those diagnosed before menopause.   13 
Conclusions 14 
This study suggests that there may be an association between occupational exposure to aliphatic 15 
and aromatic solvents and the risk of breast cancer at the low levels of exposure experienced by 16 
women in this study.   17 
 18 
Key Words: organic solvent, breast cancer, case-control study, occupational exposure, 19 
OccIDEAS.20 
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Introduction 1 
Solvents are volatile organic compounds that have the ability to dissolve a large array of 2 
materials, are lipophilic and are used widely in the workplace.  They include compounds such as 3 
benzene and other aromatic hydrocarbons and chlorinated solvents such as methylene chloride.  4 
In 1997, it was hypothesized that organic solvents act directly as genotoxic agents or indirectly 5 
through their metabolites to cause breast cancer (Labrèche and Goldberg 1997).  Evidence 6 
supporting this hypothesis is that many organic solvents have been detected in breast milk 7 
(Labrèche and Goldberg 1997; Brophy, Keith et al. 2006; Brody, Moysich et al. 2007), the 8 
majority of carcinomas occur in the lobular/duct system (Brophy, Keith et al. 2006), and some 9 
organic solvents have been shown to produce mammary gland cancer in animals (Brophy, Keith 10 
et al. 2006; Brody, Moysich et al. 2007).  Since then, a number of other studies have suggested 11 
that exposure to solvents at work is associated with about a 50% increased risk of breast cancer; 12 
(Petralia, Chow et al. 1998; Hansen 1999; Band, Le et al. 2000; Rennix, Quinn et al. 2005).   13 
A review of studies investigating occupational exposure to solvents and risk of breast cancer 14 
showed an elevated risk for jobs associated with solvent exposure, particularly chlorinated 15 
solvents, in several industries (Brody, Moysich et al. 2007).  However, the authors concluded 16 
that the existing data were inadequate and criticised many of the occupational cohort studies 17 
because the follow up periods were too short and they were cancer mortality rather than 18 
incidence studies.   19 
There is also uncertainty as to the specific type of solvent that might be associated with an 20 
increased risk of breast cancer.  In general population studies, authors have suggested that there 21 
may be associations between increased risk of breast cancer and working in particular industry 22 
sectors which can result in solvent exposure.  For example the metal product, wood and furniture, 23 
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printing, chemical and textile and clothing industries (Hansen 1999), automotive related 24 
industries (Brophy, Keith et al. 2006), electrical and electronic work (Peplonska, Stewart et al. 25 
2007) or textiles, rubber and plastics product makers (Villeneuve, Favotte et al. 2011).  These 26 
studies, however, may have been confounded by known breast cancer risk factors such as 27 
physical activity and reproductive history; factors likely to differ between women in the paid 28 
workforce and those who are not.(Brody, Moysich et al. 2007)  In addition, the use of job title to 29 
determine exposure to solvents, may have resulted in misclassification because not all those who 30 
work in the industry sector will be exposed to the solvents under study and the type of solvents 31 
used varies widely by industry sector. 32 
The aim of our study was to investigate the relationship between occupational exposure to 33 
specific types of solvents and the risk of breast cancer among women residing in Western 34 
Australia. 35 
 36 
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Methods 1 
We conducted a population-based case-control study with 1205 women aged between 18 2 
and 80 years who had a first incident invasive primary breast cancer diagnosed between 2009 3 
and 2011 identified through the Western Australian Cancer Registry, (Fritschi, Erren et al. 2013)  4 
Women with ductal carcinoma in situ, were excluded.  Cases were sent an invitation letter, 5 
consent form and questionnaire by the Cancer Registry and, if the woman consented, her details, 6 
including estrogen receptor status, were released to the study team.  Information on estrogen 7 
receptor status was missing 177 cases. 8 
We also recruited 1789 age-matched controls randomly selected from the Western 9 
Australian electoral roll.  Controls were sent a letter, consent form and questionnaire by the study 10 
team.  Control women with a previous diagnosis of invasive breast cancer were excluded.  Other 11 
ineligibility criteria for both cases and controls were having an incorrect address or not being 12 
resident in Western Australia; too unwell to participate or having inadequate English language 13 
ability.   14 
Fourteen days after initial contact, all women who had not yet responded were telephoned 15 
if a contact number was available.  A reminder letter was sent 28 days after the initial contact to 16 
any non-respondents. 17 
A self-administered questionnaire was used to collect demographic, reproductive and 18 
lifestyle factors as well as lifetime occupational history (detailed information on every job a 19 
woman had held for at least six months).  Using the web-based application OccIDEAS (Fritschi, 20 
Friesen et al. 2009), we obtained details about job characteristics by telephone interview asking 21 
questions tailored to assess solvent exposure.  The interviewer asked the participant about their 22 
job and details of the tasks carried out.  For example, a driver would be asked what kind of 23 
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vehicle they drove, what fuel it used and whether they refueled the vehicle themselves.  24 
Participants were also asked about relevant exposure circumstances of some tasks, e.g. whether it 25 
was in the open air, whether there was local exhaust ventilation or whether personal protection 26 
was used.  To limit respondent burden, where a woman had multiple jobs, we chose up to five of 27 
her jobs for the interview.  These were usually the longest held, or most different from other jobs.  28 
Algorithms applied to the interview answers provided automatic assessments which were 29 
manually reviewed to assess occupational exposure to the solvents.  Exposure was allocated as 30 
none, possible and probable to each of the following groups of solvents: aromatic solvents 31 
excluding benzene, aliphatic solvents, chlorinated solvents and alcohols based on the answers to 32 
the questions.  We also separately identified exposure to benzene.   33 
We estimated the risk of breast cancer that was associated with having ever been 34 
probably exposed one or more of the various solvent groups.  We also considered the 35 
relationship between solvents and breast cancer subtypes related to the presence of the estrogen 36 
receptor ER status, obtained from the case’s pathology records because there is evidence that the 37 
risk profiles differ for these subtypes of breast cancer (Althuis, Fergenbaum et al. 2004; Nichols, 38 
Trentham-Dietz et al. 2005).  39 
In addition the risk associated with exposure in the periods of ≤10 years, >10 to ≤20 40 
years, >20 to ≤30 years and >30 years prior to diagnosis for cases or to recruitment for controls, 41 
was compared to the risk for those who were never exposed in regression models. 42 
Logistic regression models were used to calculate odds ratios (OR) and 95% confidence 43 
intervals (CI), adjusted for age.  We also considered other known risk factors for breast cancer in 44 
the model including body mass index (BMI in their 30s), age at menarche, smoking, alcohol 45 
consumption, hormonal replacement therapy, age at first birth, parity and family history of breast 46 
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cancer.  We tested the potential confounding by these factors by adding each factor to the model 47 
for each solvent and if inclusion of factors led to a change in the OR associated with the solvent 48 
by 5% or greater it was kept it the model (Wang 2007).  A priori we hypothesized that 49 
menopause status might modify the effect of solvent exposure and we undertook a stratified 50 
analyses of the risk by menopause status.  To assess the relationship between solvents and breast 51 
cancer subtypes related to the presence of the estrogen receptor ER status we used multinomial 52 
logistic regression to calculate ORs for estrogen receptor–positive (ER+)/estrogen receptor–53 
negative (ER-) cases relative to controls.  We used STATA/IC statistical software (v 13.1, 54 
StataCorp LP, College Station, TX, USA) for all analyses. 55 
All cases and controls signed written informed consent and the research was approved by 56 
Human Research Ethics Committees of The University of Western Australia and the Department 57 
of Health, Western Australia. 58 
 59 
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Results 1 
Of the 2084 eligible cases invited to participate, 1205 consented (57.8%), 334 refused, 2 
and 545 did not respond.  Of eligible controls, 1789 (41.1%) consented to participate, 939 3 
refused, and 1628 failed to respond.  Three cases and four controls did not complete the 4 
occupational section of the questionnaire, thus were missing solvent exposure data and were 5 
excluded. 6 
Demographic characteristics are presented in Table I.  The control women who were 7 
invited to participate were frequency matched on age to the cases.   A higher proportion of 8 
younger cases participated compared with the controls, so the controls were overall slightly older 9 
than the cases, and were more likely to be post-menopausal.  Cases were more likely to have had 10 
higher education than controls but were similar in socioeconomic distributions and had similar 11 
BMIs at age 30.  As expected, cases were more likely to have a family history of breast cancer, 12 
were slightly younger at menarche, were less likely to have had children, less likely to have 13 
breastfed and less likely to have used HRT.  Cases were somewhat more likely to have ever 14 
smoked than cases.  Alcohol intake was similar for cases and controls.  The demographic details 15 
about the participants are discussed in more detail elsewhere (Fritschi, Erren et al. 2013). 16 
Thirty-one percent of respondents were ever exposed to at least one organic solvent 17 
group (29.9% controls and 32.5% cases).  Half of these participants (14.5% of the total) were 18 
exposed to one type of solvent, 7.8% of the total were exposed to two types and 8.6% to three or 19 
more types.  OccIDEAS estimates exposure as High, Medium or Low, but there were few 20 
women that were classified as ever having experienced high exposure: benzene n=1; other 21 
aromatic solvents n=6; chlorinated solvents n=4; aliphatic solvent n=2 and alcohol n=0.  A small 22 
number of women were allocated to the possible exposure category (n=46) and these were 23 
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combined with the no exposure category because exposure was not thought to be likely on 24 
reviewing their job histories.   25 
Age-adjusted breast cancer risks were modestly elevated for exposure to alcohol 26 
(OR=1.15) and to aliphatic (OR=1.21) or aromatic solvents other than benzene (OR=1.21), the 27 
risks, however were not statistically significantly raised for any of the solvent groups. (Table II)  28 
When adjustment was made for exposure to each of the other solvents, the odds ratios were 29 
reduced (ORs= 1.11, 1.01 and 1.17 respectively) (Supplementary Table I). 30 
The ORs for breast cancer and exposure to four of the five specific solvent groups (not 31 
alcohol exposure) were somewhat stronger for cancers occurring before menopause, although 32 
none of the odds ratios or interaction terms were statistically significant and the 95% CIs of the 33 
pre- and postmenopausal risk estimates overlapped. (Table II).   34 
Multinomial logistic regression showed that the presence of the ER receptor did not 35 
affect risks associated with most solvent exposures but the numbers of ER positive cases are 36 
small (see Supplementary Table II).  Exposure to alcohols showed limited evidence of an 37 
association. 38 
Examining exposure with all the time windows at different time periods before 39 
diagnosis/interview in a single regression model showed that exposure to benzene and 40 
chlorinated solvents in the last 11-20 years before diagnosis was most strongly associated with 41 
risk of breast cancer but the associations were not statistically significant. (Table III)  42 
No significant associations were observed between breast cancer and exposure before the 43 
birth of the first child to any solvents: benzene (OR=0.82, 95%CI: 0.50-1.36); other aromatic 44 
solvents (OR=1.17, 95%CI: 0.83-1.66); aliphatic solvents (OR=1.21, 95%CI: 0.88-1.68); 45 
chlorinated solvents (OR=1.34, 95%CI: 0.76-2.37); and alcohol (OR=1.03, 95%CI: 0.83-1.27).  46 
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BMI, age at menarche, smoking, alcohol consumption, hormonal replacement therapy, 47 
age at first birth, parity and family history of breast cancer had minimal effect on the solvent 48 
exposure risk estimates (<3%) so these variables were not included as adjustments of the results 49 
presented here. 50 
Solvents and breast cancer  Page 10 
Discussion 1 
Our results suggest that about a third of women in the Australian general population have 2 
been exposed to solvents at work.  When age adjusted, there is a non-statistically significantly 3 
elevated risk of breast cancer for those women exposed to solvents, the risk being more strongly 4 
associated with exposure to alcohols, aromatic and aliphatic solvents than with chlorinated 5 
solvents or benzene.   6 
Our findings are consistent with previous reports of an elevated risk of breast cancer 7 
associated with occupations where exposure to solvents is likely. (Petralia, Chow et al. 1998; 8 
Hansen 1999; Band, Le et al. 2000; Rennix, Quinn et al. 2005).  In most cases the type of solvent 9 
is not identified (Brody, Moysich et al. 2007) however a few studies identified risks associated 10 
with specific solvents or solvent groups.  Exposure to aromatic hydrocarbon solvents identified 11 
from a job-exposure matrix, was associated with increased risk of post-menopausal breast cancer, 12 
the SIR for the highest of 4 exposure levels was 1.2 (confidence intervals not provided), but no 13 
convincing association with increasing exposure to chlorinated solvents was observed 14 
(Weiderpass, Pukkala et al. 1999)  Another study identified that high probability of exposure to 15 
benzene was associated with an increased risk of breast cancer SIR 1.3 (95% CI 1.0 - 16 
1.7).(Petralia, Chow et al. 1998)  Women who worked in aircraft maintenance were exposed to a 17 
number of solvents.  When compared to unexposed workers, several solvents were associated 18 
with rather larger increased risks of breast cancer including isopropyl alcohol relative risk (RR) 19 
3.7 (95% CI 1.6 - 8.4), trichloroethane RR 3.3 (1.0 - 11.2), toluene RR 2.0 (0.9 - 4.2) and methyl 20 
ethyl ketone RR 2.1 (0.9 to 4.7).  Exposure to several of the solvents was correlated however. 21 
(Blair, Hartge et al. 1998)   22 
Our study suggests that the association is stronger for aliphatic and aromatic solvent 23 
exposure than for other solvent exposures.  Chlorinated solvent exposure was most common in 24 
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dry cleaning while aromatic and aliphatic solvent exposure occurred when handling fuel, paints 25 
and glues.  There may well have been co-exposure to several solvents, particularly for the 26 
aliphatic and aromatic solvents but our data did not show that co-exposure increased the risks of 27 
breast cancer. 28 
We did not find an increased premenopausal-cancer risk for women exposed to alcohol at 29 
work or for women exposed to any solvent.  There were fewer premenopausal cases than post-30 
menopausal diagnosed-cases so the CIs of the premenopausal cases were wider and overlapped 31 
with those of post-menopausal cases.  We did however, find that the risk was somewhat more 32 
strongly associated with premenopausal diagnosis than post-menopausal diagnosis for 33 
chlorinated, aliphatic and aromatic solvent exposures (including benzene).  This is line with 34 
other studies where premenopausal breast cancers were more likely to be solvent-related than 35 
those occurring after the menopause. (Labrèche, Goldberg et al. 2010; Ekenga, Parks et al. 2014)  36 
A recent case-control study asked participants whether they had worked with "solvents, 37 
degreasers, or other cleaning agents" in each job held after the age of 18.  Overall the risk of 38 
invasive breast cancer was not associated with lifetime exposure to solvents but the authors 39 
suggested that occupational exposure to solvents before the birth of the first child appeared to be 40 
a higher risk. (Ekenga, Parks et al. 2014)  Examining the risk in time different time periods 41 
before diagnosis has not shown consistent results. (Labrèche, Goldberg et al. 2010; Ekenga, 42 
Parks et al. 2014)   43 
The OccIDEAS methodology asks participants about specific tasks rather than specific 44 
exposures and most exposures are allocated automatically using predefined rules which is likely 45 
to reduce recall bias.  Where expert judgment was applied, this was done without knowledge of 46 
case-status.  Some non-differential bias may have occurred and this could have reduced the 47 
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observed odds ratio. (Copeland, Checkoway et al. 1977)  There is less likely to be 48 
misclassification however than using a Job-Exposure matrix where all individuals with the same 49 
job would be allocated the same exposure. 50 
This study had a relatively large number of participants who were reasonably well 51 
matched to controls.  Australian citizens over the age of 18 are legally required to join the 52 
Australian electoral roll and controls could be selected according to age bands so that they were 53 
representative sample of women in Western Australia matched to the cases on age.   54 
In Australia there is mandatory reporting of invasive cancer by pathology laboratories 55 
and other clinical sites to the state Cancer Registry.  This means that all suitable cases could be 56 
approached.  The advantage of an incidence study over a mortality study is that all cases can be 57 
included not just the fatal cases.  In addition, the individual women could be interviewed about 58 
their solvent exposure circumstances and the potential confounders of exposure such as BMI at a 59 
standard age, smoking, parity and breast feeding. 60 
When examined in the same model as solvent exposure, the most well documented risk 61 
factors (BMI, age at menarche, smoking, alcohol consumption, hormonal replacement therapy, 62 
age at first birth, parity and family history of breast cancer) did not greatly affect the risk 63 
estimates related to solvent exposure in this study.  We used BMI at age 30, but this may be 64 
inaccurately recalled, and for 354 women this information was missing.   65 
In this study, the risk of breast cancer following exposure to most solvents was not 66 
affected by presence of an ER genetic marker.  The association with alcohol was the strongest.  67 
A previous study found that for estrogen-positive and progesterone-negative tumors, the odds 68 
ratio doubled or more for each 10-year increase in exposure to monoaromatic hydrocarbons. 69 
(Labrèche, Goldberg et al. 2010)  A second study found that clinical laboratory technologists and 70 
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technicians who were ER positive and who worked with solvents were at increased risk of breast 71 
cancer, hazard ratio 2.00, (95% CI, 1.07–3.73).  This finding should be treated with caution 72 
because it was the only significantly elevated risk among 44 occupations examined, non-73 
significantly elevated risks were found for two other solvent-exposed occupations. (Ekenga, 74 
Parks et al. 2014) 75 
ER negative breast cancers are proportionally more common among premenopausally 76 
diagnosed cases than among post-menopausal cases (Althuis, Fergenbaum et al. 2004).  There 77 
were fewer pre-menopausal participants in this study, consequently there were a limited number 78 
of ER negative cases among our population. 79 
 80 
 81 
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Conclusions 1 
The risk of breast cancer was 20% elevated for women exposed to aliphatic solvents or to 2 
aromatic hydrocarbons other than benzene.  The risks were lower for those exposed to benzene 3 
and chlorinated solvents.  The solvent-associated risks were not statistically significantly 4 
elevated for women in this study but they tended to be higher for breast cancer diagnosed before 5 
menopause than post-menopause, for those exposed to benzene, aliphatic and other aromatic 6 
solvents and chlorinated solvents.  The small numbers in these sub-analyses resulted in wide CIs 7 
however. 8 
Breast cancer is relatively common and the evidence is that it is likely to be multifactorial 9 
in etiology.  It occurs later in life when a number of environmental exposures may have been 10 
experienced.  A relatively small proportion of women are exposed to solvents at work but this 11 
and other papers suggest that solvent exposure increases risk of breast cancer.  Occupational 12 
exposure is relatively easily controlled compared to other known risk factors such as genetic 13 
profile, low parity or absence of breast feeding so investigation of this could be an important 14 
source of risk reduction.   15 
A larger study which examines several occupational exposures as well as the known 16 
personal risk factors would provide more powerful evidence about the extent to which solvent 17 
exposure is a risk factor for breast cancer and which solvents are most potent.  A large case-18 
control study is needed because of the low prevalence of exposure to solvents among women, the 19 
fact that the less common pre-menopausal breast cancers appear to be most strongly associated 20 
with solvent exposure and the likelihood that only a proportion of breast cancers are associated 21 
with solvent exposure.  22 
   23 
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Table I. Demographic and reproductive characteristics of breast cancer cases and controls, 2009-2011 
 
 % Controls  
(n = 1785) 
% Cases  
(n = 1202) 












































Education Junior school 











Family history of breast cancer None 
 Some family history 
 Clear high risk 









Age at menarche 10-11 years 
12 years 













Age at first birth
b 
No children 































 No children 
 No breastfeeding 
 Breastfed ≤ 12 months 









Estrogen receptor status positive  28.6 
HRT Use of hormone replacement therapy 
None  
Estrogen only  
Progesterone only  
Estrogen + progesterone  
Mixture of treatments  
Nonhormonal treatment  










































 ≤3 drinks per week 
 4-9 drinks per week 


























Table II Breast Cancer Odds Ratios, for all women and stratified by menopausal status at time of recruitment, adjusted for age, 
comparing cases and controls with any probable solvent exposure to cases and controls with no or only possible exposure (Total 
controls 1785, total cases 1202)  (7 participants were missing solvent data) 
Solvent exposed? All participants Premenopausal Post menopausal P-value for 









































































































































Table III Breast Cancer Odds Ratios, comparing cases and controls with any probable solvent exposure to cases and controls with no 
or only possible exposure in the relevant time window before diagnosis, adjusting age and for exposures in other time windows 
Solvent exposed? Exposed ≤10 years before 
diagnosis  
Exposed 11-20 years before 
diagnosis 
Exposed 21-30 years before 
diagnosis 




Cases Odds Ratio 
(95% CI)  
Contr
ols 














































































































































































Supplementary Table I Breast Cancer Odds Ratios for all women comparing any probable solvent exposure with no or only possible exposure, 
adjusting for age and exposure to other solvents (Total controls 1785, total cases 1202)  (7 participants were missing solvent data)  
 
Solvent exposed? All participants 




0.88 (0.56 - 1.31) 
Other aromatic No 
Yes 
1.00 
















Supplementary Table II Breast cancer subtype risk (ER positive and negative cases) associated with likelihood of exposure to any probable 
solvent relative to controls, adjusted for age (multinomial logistic regression) 
Solvent Exposed? Control ER negative cases ER positive cases Overall P-value 
for difference 
between either 
case groups with 





ER- cases  






13 1.35 (0.74 – 2.48) 
802 








24 1.34 (0.85 – 2.12) 
741 






29 1.24 (0.81 – 1.90) 
704 






6 1.28 (0.54 – 3.04) 
828 






31 0.86 (0.57 – 1.29) 
643 








48 0.96 (0.68 – 1.37) 
562 
294 1.25 (1.05 – 1.48) 0.04 0.16 
 
